Frequently Asked Questions
An Anti-Müllerian Hormone (AMH) test measures the level of AMH hormone in your blood. This hormone is produced by small follicles in the ovaries and helps estimate your ovarian reserve, or the number of eggs remaining. The AMH test is widely used during fertility evaluations because it provides valuable information about reproductive potential. It can help doctors understand how your ovaries may respond to fertility treatments such as IVF or ovulation induction. However, AMH does not measure egg quality or guarantee pregnancy. Women with both high and low AMH levels can still conceive naturally depending on several other factors. The test is usually performed through a simple blood sample and can be done on any day of the menstrual cycle. Your fertility specialist interprets the results alongside age, ultrasound findings, hormone levels, and medical history to provide personalized fertility guidance.
Yes, many women with low AMH levels can still become pregnant naturally. A low AMH level mainly indicates a reduced ovarian reserve, meaning fewer eggs remain in the ovaries. It does not necessarily reflect the quality of the eggs or your ability to conceive immediately. Age, ovulation, sperm health, fallopian tube function, and overall reproductive health all influence fertility. Some women with low AMH conceive without medical assistance, while others may benefit from fertility treatments. Because ovarian reserve declines over time, early consultation with a fertility specialist is recommended if pregnancy is being delayed. Timely evaluation allows doctors to discuss suitable treatment options and family planning strategies based on your individual fertility profile.
No, a high AMH level does not automatically mean better fertility. High AMH generally suggests a larger ovarian reserve, but it does not indicate egg quality or guarantee successful conception. In some women, especially those with Polycystic Ovary Syndrome (PCOS), AMH levels may be significantly elevated. Although more eggs may be present, ovulation can still be irregular, making pregnancy more difficult without treatment. High AMH can also increase the risk of ovarian hyperstimulation during fertility treatments, requiring careful monitoring. Fertility specialists consider high AMH together with ultrasound findings, menstrual history, age, and other hormone tests before making treatment recommendations.
No, the AMH test does not measure egg quality. It only estimates the number of eggs remaining in the ovaries by assessing ovarian reserve. Egg quality is influenced primarily by age and genetic factors rather than AMH levels. A younger woman with low AMH may still have healthy, high-quality eggs, while an older woman with higher AMH may experience reduced egg quality due to natural aging. Because both egg quantity and quality affect fertility, doctors evaluate AMH alongside age, ultrasound scans, hormone tests, and overall reproductive health. This comprehensive assessment provides a more accurate understanding of fertility potential than AMH alone.
An AMH test may be recommended for women who have been trying to conceive without success, have irregular menstrual cycles, are considering IVF, or wish to assess their fertility before delaying pregnancy. It may also be advised for women with a family history of early menopause, previous ovarian surgery, endometriosis, or certain medical treatments that could affect ovarian function. Women diagnosed with PCOS may also undergo AMH testing as part of their fertility evaluation. While AMH provides useful information about ovarian reserve, it is not a routine screening test for every woman. A fertility specialist can determine whether AMH testing is appropriate based on your medical history and reproductive goals.
During IVF treatment, AMH levels help fertility specialists estimate how the ovaries may respond to stimulation medications. Women with higher AMH levels often produce more eggs during ovarian stimulation, while those with lower AMH may produce fewer eggs. This information allows doctors to personalize medication doses and treatment protocols to improve safety and outcomes. However, AMH alone does not predict embryo quality, implantation success, or live birth rates. Many patients with low AMH have successful IVF pregnancies, while others with high AMH may still face fertility challenges. IVF planning always includes additional factors such as age, ultrasound findings, sperm quality, and previous treatment history.
Currently, there is no scientifically proven method to significantly increase AMH levels or permanently restore ovarian reserve. Some lifestyle changes such as maintaining a healthy weight, eating a balanced diet, avoiding smoking, limiting alcohol consumption, managing stress, and exercising regularly can support overall reproductive health. Certain supplements are sometimes recommended, but evidence regarding their ability to improve AMH remains limited. Rather than focusing solely on increasing AMH, fertility specialists develop treatment plans based on your current ovarian reserve and reproductive goals. Early fertility assessment and timely intervention often play a more important role than attempting to raise AMH levels.
No, AMH results should never be interpreted in isolation. Although AMH is an important marker of ovarian reserve, it represents only one part of a complete fertility evaluation. Doctors combine AMH results with age, menstrual history, pelvic ultrasound, antral follicle count, hormone tests such as FSH and estradiol, sperm analysis, and overall medical history. These combined findings help determine fertility potential and identify the most appropriate treatment options. Misinterpreting AMH alone may lead to unnecessary anxiety or false reassurance. Consulting an experienced fertility specialist ensures accurate interpretation and personalized recommendations for achieving pregnancy.

